During the past decade, AdventHealth Celebration Infusion Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AdventHealth Celebration Infusion Center" are "Advanced Solid Tumors" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Metastatic Solid Tumors" (1 trials). Many other conditions were trialed in "AdventHealth Celebration Infusion Center" in a lesser frequency.

Most popular intervention types in "AdventHealth Celebration Infusion Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Axitinib" (1 trials), "Binimetinib" (1 trials), "Encorafenib" (1 trials), "PF-06939999 dose escalation" (1 trials) and "PF-06939999 in combination with docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "AdventHealth Celebration Infusion Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AdventHealth Celebration Infusion Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AdventHealth Celebration Infusion Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AdventHealth Celebration Infusion Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".